Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Receptors, Prostaglandin MeSH Descriptor Data 2025
Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors).
Entry Version
RECEPT PG
Entry Term(s)
Prostaglandin Receptor
Prostaglandin Receptors
Receptor, Prostaglandin
Receptors, Prostaglandins
Registry Numbers
0
NLM Classification #
QU 91
Previous Indexing
Prostaglandins (1966-1976)
Receptors, Drug (1968-1976)
Public MeSH Note
87; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86
History Note
87(77); was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86
Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors).